Iranian Red Crescent Medical Journal

Published by: Kowsar

Association of Mammographic Density with Pathologic Findings

Nasrin Ahmadinejad 1 , Samaneh Movahedinia 2 , Sajjadeh Movahedinia 2 , * and Mona Shahriari 2
Authors Information
1 Advanced Diagnostic and Interventional Radiology Research Center (ADIR), Tehran University of Medical Sciences (TUMS), Tehran, IR Iran
2 School of Medicine, Tehran University of Medical Sciences (TUMS), Tehran, IR Iran
Article information
  • Iranian Red Crescent Medical Journal: December 5, 2013, 15 (12); e16698
  • Published Online: December 5, 2013
  • Article Type: Research Article
  • Received: February 22, 2013
  • Revised: June 25, 2013
  • Accepted: August 27, 2013
  • DOI: 10.5812/ircmj.16698

To Cite: Ahmadinejad N, Movahedinia S, Movahedinia S, Shahriari M. Association of Mammographic Density with Pathologic Findings, Iran Red Crescent Med J. 2013 ; 15(12):e16698. doi: 10.5812/ircmj.16698.

Copyright © 2013, Iranian Red Crescent Medical Journal. This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License ( which permits copy and redistribute the material just in noncommercial usages, provided the original work is properly cited.
1. Backgrtound
2. Objectives
3. Patients and Methods
4. Results
4. Discussion
  • 1. Parkin DM, Bray F, Ferlay J, Pisani P. Global cancer statistics, 2002. CA Cancer J Clin. 2005; 55(2): 74-108[PubMed]
  • 2. Wilson CM, Tobin S, Young RC. The exploding worldwide cancer burden: the impact of cancer on women. Int J Gynecol Cancer. 2004; 14(1): 1-11[PubMed]
  • 3. Firouznia K, Ghanaati H, Sharafi A, Abahashemi F, Hashemi H, Jalali AH, et al. Comparing Ovarian Radiation Doses in Flat-Panel and Conventional Angiography During Uterine Artery Embolization: A Randomized Clinical Trial. Iran J Radiol. 2013; 10(3): 111-115[DOI]
  • 4. Dite GS, Jenkins MA, Southey MC, Hocking JS, Giles GG, McCredie MR, et al. Familial risks, early-onset breast cancer, and BRCA1 and BRCA2 germline mutations. J Natl Cancer Inst. 2003; 95(6): 448-57[PubMed]
  • 5. Peto Julian, Collins Nadine, Barfoot Rita, Seal Sheila, Warren William, Rahman Nazneen, et al. Prevalence of BRCA1 and BRCA2 Gene Mutations in Patients With Early-Onset Breast Cancer. Journal of the National Cancer Institute. 1999; 91(11): 943-949[DOI]
  • 6. Yazar E, Seçik F, Yıldız P. Does Repeating CT-Guided Transthoracic Fine Needle Aspiration Increase Diagnostic Yield and Complication Rate? A Single Institution Experience. Iran J Radiol. 2013; 10(2): 56-60[DOI]
  • 7. Moradi M, Ganji K, Teyfouri N, Kolahdoozan F. Performance of Double Reading Mammography in an Iranian Population and Its Effect on Patient Outcome. Iran J Radiol. 2013; 10(2): 51-5[DOI]
  • 8. Wolfe JN, Saftlas AF, Salane M. Mammographic parenchymal patterns and quantitative evaluation of mammographic densities: a case-control study. AJR Am J Roentgenol. 1987; 148(6): 1087-92[DOI][PubMed]
  • 9. Nadrljanski MM, Markovic BB, Milosevic ZC. Breast ductal carcinoma in situ: morphologic and kinetic MRI findings. Iran J Radiol. 2013; 10(2): 99-102[DOI][PubMed]
  • 10. Rashidi L, Vasheghani-Farahani E, Rostami K, Gangi F, Fallahpour M. Mesoporous Silica Nanoparticles as a Nanocarrier for Delivery of Vitamin C. Iran J Biotech. 2013; 11(4): 209-213[DOI]
  • 11. Nawawi O, Ying Goh K, Rahmat K. A rare case of primary infiltrating neuroendocrine carcinoma of the breast. Iran J Radiol. 2012; 9(4): 212-6[DOI][PubMed]
  • 12. Dahlstrom JE, Jain S, Sutton T, Sutton S. Diagnostic accuracy of stereotactic core biopsy in a mammographic breast cancer screening programme. Histopathology. 1996; 28(5): 421-7[PubMed]
  • 13. Liberman L, LaTrenta LR, Van Zee KJ, Morris EA, Abramson AF, Dershaw DD. Stereotactic core biopsy of calcifications highly suggestive of malignancy. Radiology. 1997; 203(3): 673-7[DOI][PubMed]
  • 14. Gill JK, Maskarinec G, Pagano I, Kolonel LN. The association of mammographic density with ductal carcinoma in situ of the breast: the Multiethnic Cohort. Breast Cancer Res. 2006; 8(3)[DOI][PubMed]
  • 15. Cecchini RS, Costantino JP, Cauley JA, Cronin WM, Wickerham DL, Bandos H, et al. Baseline mammographic breast density and the risk of invasive breast cancer in postmenopausal women participating in the NSABP study of tamoxifen and raloxifene (STAR). Cancer Prev Res (Phila). 2012; 5(11): 1321-9[DOI][PubMed]
  • 16. Ursin G, Hovanessian-Larsen L, Parisky YR, Pike MC, Wu AH. Greatly increased occurrence of breast cancers in areas of mammographically dense tissue. Breast Cancer Res. 2005; 7(5)-8[DOI][PubMed]
  • 17. Papantoniou V, Tsiouris S, Mainta E, Valotassiou V, Souvatzoglou M, Sotiropoulou M, et al. Imaging in situ breast carcinoma (with or without an invasive component) with technetium-99m pentavalent dimercaptosuccinic acid and technetium-99m 2-methoxy isobutyl isonitrile scintimammography. Breast Cancer Res. 2005; 7(1)-45[DOI][PubMed]
  • 18. Aiello EJ, Buist DS, White E, Porter PL. Association between mammographic breast density and breast cancer tumor characteristics. Cancer Epidemiol Biomarkers Prev. 2005; 14(3): 662-8[DOI][PubMed]
  • 19. Greendale GA, Reboussin BA, Slone S, Wasilauskas C, Pike MC, Ursin G. Postmenopausal hormone therapy and change in mammographic density. J Natl Cancer Inst. 2003; 95(1): 30-7[PubMed]
  • 20. Byrne C, Schairer C, Wolfe J, Parekh N, Salane M, Brinton LA, et al. Mammographic features and breast cancer risk: effects with time, age, and menopause status. J Natl Cancer Inst. 1995; 87(21): 1622-9[PubMed]
  • 21. Ghosh K, Brandt KR, Sellers TA, Reynolds C, Scott CG, Maloney SD, et al. Association of mammographic density with the pathology of subsequent breast cancer among postmenopausal women. Cancer Epidemiol Biomarkers Prev. 2008; 17(4): 872-9[DOI][PubMed]
  • 22. Roubidoux MA, Bailey JE, Wray LA, Helvie MA. Invasive cancers detected after breast cancer screening yielded a negative result: relationship of mammographic density to tumor prognostic factors. Radiology. 2004; 230(1): 42-8[DOI][PubMed]
  • 23. Ziv E, Tice J, Smith-Bindman R, Shepherd J, Cummings S, Kerlikowske K. Mammographic density and estrogen receptor status of breast cancer. Cancer Epidemiol Biomarkers Prev. 2004; 13(12): 2090-5[PubMed]
  • 24. Tamimi RM, Hankinson SE, Colditz GA, Byrne C. Endogenous sex hormone levels and mammographic density among postmenopausal women. Cancer Epidemiol Biomarkers Prev. 2005; 14(11 Pt 1): 2641-7[DOI][PubMed]
  • 25. Judy LC, Gunnar JC. Advances in Breast Cancer Detection with Screening Mammography. Ochsner J. 2000; 2(1): 33–35
  • 26. Haars G, van Noord PA, van Gils CH, Grobbee DE, Peeters PH. Measurements of breast density: no ratio for a ratio. Cancer Epidemiol Biomarkers Prev. 2005; 14(11 Pt 1): 2634-40[DOI][PubMed]
  • 27. Baines CJ, Miller AB, Wall C, McFarlane DV, Simor IS, Jong R, et al. Sensitivity and specificity of first screen mammography in the Canadian National Breast Screening Study: a preliminary report from five centers. Radiology. 1986; 160(2): 295-8[DOI][PubMed]
  • 28. Kavanagh AM, Giles GG, Mitchell H, Cawson JN. The sensitivity, specificity, and positive predictive value of screening mammography and symptomatic status. J Med Screen. 2000; 7(2): 105-10[PubMed]
  • 29. Hofvind S, Geller BM, Skelly J, Vacek PM. Sensitivity and specificity of mammographic screening as practised in Vermont and Norway. Br J Radiol. 2012; 85(1020)-32[DOI][PubMed]
  • 30. Ansari Basir S, Adeli K. MicroRNAs: Critical Regulators of mRNA Traffic and Translational Control with Promising Biotech and Therapeutic Applications. Iran J Biotech. 2013; 11(3): 147-55[DOI]
  • 31. Lacquement Melissa A, Mitchell Debra, Hollingsworth Alan B. Positive predictive value of the breast imaging reporting and data system1 1 No competing interests declared. J Am Coll Surg. 1999; 189(1): 34-40
  • 32. Lazarus E, Mainiero MB, Schepps B, Koelliker SL, Livingston LS. BI-RADS lexicon for US and mammography: interobserver variability and positive predictive value. Radiology. 2006; 239(2): 385-91[DOI][PubMed]
  • 33. Maletzki C, Bodammer P, Breitrück A, Kerkhoff C.. S100 Proteins as Diagnostic and Prognostic Markers in Colorectal and Hepatocellular Carcinoma. Hepat Mon 2012; 12(10 HCC)
  • 34. Timucin M, Alagozlu H, Ozdemir S, Ozdemir O. Association Between ABCB1 (MDR1) Gene Polymorphism and Unresponsiveness Combined Therapy in Chronic Hepatitis C virus. Hepat Mon 2013; 13(4)
  • 35. Abu El Makarem M.. An Overview of Biomarkers for the Diagnosis of Hepatocellular Carcinoma. Hepat Mon 2012; 12(10 HCC)
Creative Commons License Except where otherwise noted, this work is licensed under Creative Commons Attribution Non Commercial 4.0 International License .

Search Relations:



Create Citiation Alert
via Google Reader

Readers' Comments